Bellevue Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,700
| Closed | -$320K | – | 154 |
|
|
2024
Q4 | $320K | Hold |
15,700
| – | – | 0.01% | 135 |
|
|
2024
Q3 | $457K | Buy |
+15,700
| New | +$457K | 0.01% | 131 |
|
|
2023
Q3 | – | Sell |
-44,050
| Closed | -$1.3M | – | 158 |
|
|
2023
Q2 | $1.3M | Buy |
44,050
+13,050
| +42% | +$385K | 0.02% | 120 |
|
|
2023
Q1 | $714K | Hold |
31,000
| – | – | 0.01% | 136 |
|
|
2022
Q4 | $862K | Hold |
31,000
| – | – | 0.01% | 139 |
|
|
2022
Q3 | $951K | Buy |
+31,000
| New | +$951K | 0.01% | 137 |
|